TCWM
ICCC icon

Total Clarity Wealth Management’s ImmuCell ICCC Stock Holding History

Total Clarity Wealth Management’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-701
Closed -$6K – 559
2022
Q2 		$6K Buy
+701
New +$6.08K ﹤0.01% 781
2022
Q1 		– Sell
-648
Closed -$5K – 516
2021
Q4 		$5K Buy
+648
New +$5.79K ﹤0.01% 803

Other funds holding ICCC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SRC
Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
OMC
Overbrook Management Corp New York $663M AUM 35.04% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

Total Clarity Wealth Management's ICCC Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of ImmuCell (ICCC) in Q3 2022, closing a stake of 701 shares — an estimated $6K sold.

Total Clarity Wealth Management first reported a position in ICCC in Q4 2021 and held it in 2 quarters. The position peaked at $6K in Q2 2022. 26 funds tracked by Wall St. Rank hold ICCC as of Q3 2022.

  • Total Clarity Wealth Management reported no remaining ImmuCell position as of Q3 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 701 ImmuCell shares in Q3 2022, an estimated $6K.
  • Total Clarity Wealth Management first reported a position in ImmuCell in Q4 2021 and held it in 2 quarters.
  • Total Clarity Wealth Management's ImmuCell position peaked at $6K in Q2 2022.
  • 26 funds tracked by Wall St. Rank held ImmuCell as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.